AR076524A1 - Forma cristalina de un compuesto de benzopirano triciclico y metodo de produccion de la misma - Google Patents
Forma cristalina de un compuesto de benzopirano triciclico y metodo de produccion de la mismaInfo
- Publication number
- AR076524A1 AR076524A1 ARP100101484A ARP100101484A AR076524A1 AR 076524 A1 AR076524 A1 AR 076524A1 AR P100101484 A ARP100101484 A AR P100101484A AR P100101484 A ARP100101484 A AR P100101484A AR 076524 A1 AR076524 A1 AR 076524A1
- Authority
- AR
- Argentina
- Prior art keywords
- crystal
- phenethylamino
- quinolin
- pyran
- dihydro
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title 1
- 239000013078 crystal Substances 0.000 abstract 12
- IQQDNMHUOLMLNJ-UHFFFAOYSA-N quinolin-3-ol Chemical compound C1=CC=CC2=CC(O)=CN=C21 IQQDNMHUOLMLNJ-UHFFFAOYSA-N 0.000 abstract 8
- 239000000843 powder Substances 0.000 abstract 6
- 239000002904 solvent Substances 0.000 abstract 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 abstract 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
- 150000002825 nitriles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Proveer formas cristalinas de (3R,4S)-7-hidroximetil-2,2,9-trimetil-4-(fenetilamino)-3,4-dihidro-2H-pirano[2,3-g]quinolin-3-ol a utilizarse como un fármaco, y métodos de produccion de las mismas. Métodos de produccion que incluyen cristalizar (3R,4S)-7-hidroximetil-2,2,9-trimetil-4-(fenetilamino)-3,4-dihidro-2H-pirano[2,3-g]quinolin-3-ol a partir de un solvente de éster de acetato, un solvente hidrocarbonado alifático, un solvente de nitrilo, un solvente hidrocarbonado aromático, un solvente de cetona o un solvente de éter, y formas cristalinas obtenidas de acuerdo con los métodos. Reivindicacion 1: Un cristal de forma A de (3R,4S)-7-hidroximetil-2,2,9-trimetil-4-(fenetilamino)-3,4-dihidro-2H-pirano[2,3-g]quinolin-3-ol de la formula (1): caracterizado porque tiene valores máximos característicos en ángulos de difraccion (2theta) de 5,6, 8,2, 12,0, 14,7, 16,6, 16,9, 17,9, 18,4, 22,5, 24,5, 27,6 en un difractograma de rayos X en polvo del cristal. Reivindicacion 7: Un cristal de forma B de (3R,4S)-7-hidroximetil-2,2,9-trimetil-4-(fenetilamino)-3,4-dihidro-2H-pirano[2,3-g]quinolin-3-ol de la formula (1): caracterizado porque tiene valores máximos característicos en ángulos de difraccion (2theta) de 6,4, 8,7, 12,8, 17,5, 19,1, 20,7, 22,0, 24,8, 26,6 en un difractograma de rayos X en polvo del cristal. Reivindicacion 8: Un cristal de forma E de (3R,4S)-7-hidroximetil-2,2,9-trimetil-4-(fenetilamino)-3,4-dihidro-2H-pirano[2,3-g]quinolin-3-ol de la formula (1): caracterizado porque tiene valores máximos característicos en ángulos de difraccion (2theta) de 9,1, 12,8, 13,1, 14,6, 15,2, 16,4, 22,1, 23,6, 24,8 en un difractograma de rayos X en polvo del cristal. Reivindicacion 9: Un cristal de forma F de (3R,4S)-7-hidroximetil-2,2,9-trimetil-4-(fenetilamino)-3,4-dihidro-2H-pirano[2,3-g]quinolin-3-ol de la formula (1): caracterizado porque tiene valores máximos característicos en ángulos de difraccion (2theta) de 6,8, 11,7, 13,7, 16,8, 18,0, 19,3, 20,4, 20,8, 24,6, 25,6 en un difractograma de rayos X en polvo del cristal. Reivindicacion 10: Un cristal de forma G de (3R,4S)-7-hidroximetil-2,2,9-trimetil-4-(fenetilamino)-3,4-dihidro-2H-pirano[2,3-g]quinolin-3-ol de la formula (1): caracterizado porque tiene valores máximos característicos en ángulos de difraccion (2theta) de 6,7, 11,6, 11,9, 13,6, 16,6, 17,7, 18,6, 19,1, 19,8, 20,1, 20,8 en un difractograma de rayos X en polvo del cristal. Reivindicacion 11: Un cristal de forma H de (3R,4S)-7-hidroximetil-2,2,9-trimetil-4-(fenetilamino)-3,4-dihidro-2H-pirano[2,3-g]quinolin-3-ol de la formula (1): caracterizado porque tiene valores máximos característicos en ángulos de difraccion (2theta) de 6,0, 16,4, 17,0, 19,2, 19,8, 20,3, 21,0, 22,8 en un difractograma de rayos X en polvo del cristal.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009111281 | 2009-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR076524A1 true AR076524A1 (es) | 2011-06-15 |
Family
ID=43032280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100101484A AR076524A1 (es) | 2009-04-30 | 2010-04-30 | Forma cristalina de un compuesto de benzopirano triciclico y metodo de produccion de la misma |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9242992B2 (es) |
| EP (1) | EP2426133B1 (es) |
| JP (1) | JP5664870B2 (es) |
| KR (1) | KR101703202B1 (es) |
| CN (1) | CN102414213B (es) |
| AR (1) | AR076524A1 (es) |
| AU (1) | AU2010242339B2 (es) |
| BR (1) | BRPI1007112A2 (es) |
| CA (1) | CA2759073C (es) |
| ES (1) | ES2562027T3 (es) |
| IL (1) | IL215930A (es) |
| MX (1) | MX340918B (es) |
| NZ (1) | NZ596060A (es) |
| PL (1) | PL2426133T3 (es) |
| RU (1) | RU2523279C2 (es) |
| SG (1) | SG175377A1 (es) |
| TW (1) | TWI480281B (es) |
| UA (1) | UA105385C2 (es) |
| WO (1) | WO2010126138A1 (es) |
| ZA (1) | ZA201107662B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220071951A1 (en) | 2018-12-28 | 2022-03-10 | Osaka University | Therapeutic agent for inherited bradyarrhythmia |
| KR102819183B1 (ko) | 2019-03-29 | 2025-06-13 | 한미약품 주식회사 | 퓨로피리미딘 화합물의 산 부가염의 결정형 |
| EP4083040A4 (en) | 2020-01-21 | 2024-04-24 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | IRAQ4 INHIBITOR CRYSTAL AND PREPARATION METHOD THEREFOR |
| JP7733887B2 (ja) * | 2020-06-26 | 2025-09-04 | 国立大学法人大阪大学 | 薬剤誘発性徐脈および徐脈性不整脈治療薬 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2446497A1 (de) * | 1974-09-28 | 1976-04-08 | Boehringer Sohn Ingelheim | 4-oxo-4h-pyrano- eckige klammer auf 3,2-c eckige klammer zu -chinolin-2-carbonsaeuren und ihre salze |
| US5164509A (en) * | 1990-11-26 | 1992-11-17 | E. R. Squibb & Sons, Inc. | Benzodiazolo analogs |
| GB9224169D0 (en) * | 1992-11-18 | 1993-01-06 | Lilly Industries Ltd | Pharmaceutical compounds |
| KR960700713A (ko) * | 1993-04-02 | 1996-02-24 | 도쿠시마 슈이치 | 심부전증 치료약(medicines for cardiac insufficiency) |
| EP0807629B1 (de) * | 1996-05-15 | 2004-03-03 | Aventis Pharma Deutschland GmbH | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| EP0918774B9 (en) * | 1996-06-27 | 2002-04-10 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
| UA91189C2 (en) * | 2004-03-23 | 2010-07-12 | Ниссан Кемикал Индастриз, Лтд. | Tricyclic benzopyran compound as anti-arrhythmic agents |
-
2010
- 2010-04-30 PL PL10769836T patent/PL2426133T3/pl unknown
- 2010-04-30 CA CA2759073A patent/CA2759073C/en active Active
- 2010-04-30 ES ES10769836.7T patent/ES2562027T3/es active Active
- 2010-04-30 UA UAA201114121A patent/UA105385C2/uk unknown
- 2010-04-30 TW TW099113885A patent/TWI480281B/zh active
- 2010-04-30 JP JP2011511472A patent/JP5664870B2/ja active Active
- 2010-04-30 WO PCT/JP2010/057698 patent/WO2010126138A1/ja not_active Ceased
- 2010-04-30 AR ARP100101484A patent/AR076524A1/es not_active Application Discontinuation
- 2010-04-30 MX MX2011011329A patent/MX340918B/es active IP Right Grant
- 2010-04-30 BR BRPI1007112-1A patent/BRPI1007112A2/pt active Search and Examination
- 2010-04-30 NZ NZ596060A patent/NZ596060A/xx unknown
- 2010-04-30 KR KR1020117028198A patent/KR101703202B1/ko active Active
- 2010-04-30 US US13/318,230 patent/US9242992B2/en active Active
- 2010-04-30 EP EP10769836.7A patent/EP2426133B1/en active Active
- 2010-04-30 AU AU2010242339A patent/AU2010242339B2/en not_active Ceased
- 2010-04-30 SG SG2011079126A patent/SG175377A1/en unknown
- 2010-04-30 CN CN201080018858.0A patent/CN102414213B/zh active Active
- 2010-04-30 RU RU2011148595/04A patent/RU2523279C2/ru active
-
2011
- 2011-10-19 ZA ZA2011/07662A patent/ZA201107662B/en unknown
- 2011-10-25 IL IL215930A patent/IL215930A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010242339B2 (en) | 2015-10-01 |
| TWI480281B (zh) | 2015-04-11 |
| ZA201107662B (en) | 2012-12-27 |
| UA105385C2 (uk) | 2014-05-12 |
| NZ596060A (en) | 2012-12-21 |
| IL215930A (en) | 2016-09-29 |
| HK1166501A1 (en) | 2012-11-02 |
| EP2426133A4 (en) | 2013-01-09 |
| TW201111387A (en) | 2011-04-01 |
| KR20120024655A (ko) | 2012-03-14 |
| RU2011148595A (ru) | 2013-06-10 |
| US20120059169A1 (en) | 2012-03-08 |
| CN102414213A (zh) | 2012-04-11 |
| BRPI1007112A2 (pt) | 2015-08-18 |
| SG175377A1 (en) | 2011-12-29 |
| RU2523279C2 (ru) | 2014-07-20 |
| AU2010242339A1 (en) | 2011-11-17 |
| MX2011011329A (es) | 2011-11-18 |
| PL2426133T3 (pl) | 2016-04-29 |
| US9242992B2 (en) | 2016-01-26 |
| CN102414213B (zh) | 2014-12-24 |
| JP5664870B2 (ja) | 2015-02-04 |
| EP2426133B1 (en) | 2015-12-16 |
| CA2759073C (en) | 2017-03-14 |
| CA2759073A1 (en) | 2010-11-04 |
| IL215930A0 (en) | 2011-12-29 |
| JPWO2010126138A1 (ja) | 2012-11-01 |
| MX340918B (es) | 2016-07-20 |
| ES2562027T3 (es) | 2016-03-02 |
| KR101703202B1 (ko) | 2017-02-06 |
| EP2426133A1 (en) | 2012-03-07 |
| WO2010126138A1 (ja) | 2010-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900793A1 (ru) | Способ получения эзетимиба и его производных | |
| MX355428B (es) | Formas cristalinas del acido [ (4-hidroxi-1-metil-7-fenoxi-isoquin olin-3-carbonil) -amino] -acetico inhibidor de prolil hidroxilasa. | |
| MX353553B (es) | Metodo para producir derivados de 4,4-difluoro-3,4-dihidroisoquino lina. | |
| BR112015006874A2 (pt) | ligantes de rig-i inovadores e métodos para produzir os mesmos | |
| WO2015077635A3 (en) | Macromolecular antioxidants based on dual type moiety per molecule: structures methods of making and using the same | |
| WO2015008218A3 (en) | Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant | |
| WO2014153188A3 (en) | High efficiency, small volume nucleic acid synthesis | |
| WO2012138147A3 (en) | 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof | |
| MX360062B (es) | Metodos de elaboracion de fenilacetato de l-ornitina. | |
| MX2009007436A (es) | Derivados espirociclicos de acido tetronico. | |
| MX360855B (es) | Procedimiento para la preparación de una composición que comprende complejos metálicos en una matriz orgánica aceitosa. | |
| MY176977A (en) | Method for preparing cysteine or a derivative thereof using a novel o-phosphoserine sulfhydrylase | |
| PH12015501807A1 (en) | Vortioxetine manufacturing process | |
| BR112015022529A2 (pt) | meios de cultura de células e processos de produção de anticorpo | |
| AR076524A1 (es) | Forma cristalina de un compuesto de benzopirano triciclico y metodo de produccion de la misma | |
| WO2015042414A8 (en) | Multicyclic compounds and methods of using same | |
| ATE512931T1 (de) | Verfahren zur herstellung von ammoniumheptamolybdat | |
| NZ720340A (en) | Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulene and crystalline forms thereof | |
| MY165513A (en) | Compositions comprising extracts obtained from oil palm based materials for providing anti-inflammatory effects and method of producing thereof | |
| MX2016000141A (es) | El uso de piridonacarboxamidas seleccionadas o sales de las mismas como sustancias activas contra el estres abiotico de las plantas. | |
| WO2014115174A8 (en) | Novel approach for synthesis of catechins | |
| EA200870320A1 (ru) | Способ получения г-ксф человека | |
| EA201300792A1 (ru) | Химические соединения | |
| EA200971019A1 (ru) | Способы получения (r)-2-метилпирролидина и (s)-2-метилпирролидина и их солей винной кислоты | |
| GB2523674A (en) | Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |